Literature DB >> 11888242

Neurobiology of neuropathic pain: mode of action of anticonvulsants.

Anthony H Dickenson1, Elizabeth A Matthews, Rie Suzuki.   

Abstract

Anticonvulsants are widely used for the treatment of neuropathic pain. Here we review the evidence for a number of peripheral and central changes after nerve injury that may provide a basis for the mechanisms of action of anticonvulsant therapies. The roles of sodium channels, calcium channels, and central glutamate mechanisms are emphasized as the main targets for anticonvulsant drugs in neuropathic pain states. The focus of this article is on anticonvulsants; however, opioids and antidepressants can also be effective in increasing inhibitions to control of pain in a manner similar to that of the enhancement of gamma-aminobutyric acid (GABA) function by antiepileptic drugs. A brief account of these approaches to neuropathic pain is also given. Copyright 2002 European Federation of Chapters of the International Association for the Study of Pain

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11888242     DOI: 10.1053/eujp.2001.0323

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  13 in total

Review 1.  Recent developments: management of pain.

Authors:  Anita Holdcroft; Ian Power
Journal:  BMJ       Date:  2003-03-22

2.  Preclinical Comparison of Mechanistically Different Antiseizure, Antinociceptive, and/or Antidepressant Drugs in a Battery of Rodent Models of Nociceptive and Neuropathic Pain.

Authors:  Misty D Smith; Jose H Woodhead; Laura J Handy; Timothy H Pruess; Fabiola Vanegas; Erin Grussendorf; Joel Grussendorf; Karen White; Karolina K Bulaj; Reisa K Krumin; Megan Hunt; Karen S Wilcox
Journal:  Neurochem Res       Date:  2017-05-15       Impact factor: 3.996

3.  Weighing the balance: how analgesics used in chronic pain influence sleep?

Authors:  Miqdad H Bohra; Chhavi Kaushik; Daniel Temple; Sharon A Chung; Colin M Shapiro
Journal:  Br J Pain       Date:  2014-08

Review 4.  Diabetic neuropathic pain: Physiopathology and treatment.

Authors:  Anne K Schreiber; Carina Fm Nones; Renata C Reis; Juliana G Chichorro; Joice M Cunha
Journal:  World J Diabetes       Date:  2015-04-15

5.  Merging the structural motifs of functionalized amino acids and alpha-aminoamides: compounds with significant anticonvulsant activities.

Authors:  Christophe Salomé; Elise Salomé-Grosjean; James P Stables; Harold Kohn
Journal:  J Med Chem       Date:  2010-05-13       Impact factor: 7.446

6.  Identification of the benzyloxyphenyl pharmacophore: a structural unit that promotes sodium channel slow inactivation.

Authors:  Amber M King; Xiao-Fang Yang; Yuying Wang; Erik T Dustrude; Cindy Barbosa; Michael R Due; Andrew D Piekarz; Sarah M Wilson; Fletcher A White; Christophe Salomé; Theodore R Cummins; Rajesh Khanna; Harold Kohn
Journal:  ACS Chem Neurosci       Date:  2012-09-19       Impact factor: 4.418

7.  Custom distinctions in the interaction of G-protein beta subunits with N-type (CaV2.2) versus P/Q-type (CaV2.1) calcium channels.

Authors:  Heather L Agler; Jenafer Evans; Henry M Colecraft; David T Yue
Journal:  J Gen Physiol       Date:  2003-06       Impact factor: 4.086

Review 8.  Oxcarbazepine for neuropathic pain.

Authors:  Muke Zhou; Ning Chen; Li He; Mi Yang; Cairong Zhu; Fengbo Wu
Journal:  Cochrane Database Syst Rev       Date:  2017-12-02

9.  Pharmacological evaluation of rat dorsal root ganglion neurons as an in vitro model for diabetic neuropathy.

Authors:  Eve Peeraer; An Van Lutsenborg; An Verheyen; Raf De Jongh; Rony Nuydens; Theo F Meert
Journal:  J Pain Res       Date:  2011-02-14       Impact factor: 3.133

Review 10.  Mechanisms and management of diabetic painful distal symmetrical polyneuropathy.

Authors:  Solomon Tesfaye; Andrew J M Boulton; Anthony H Dickenson
Journal:  Diabetes Care       Date:  2013-09       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.